TY  - CHAP
M1  - Book, Section
TI  - Allergic Bronchopulmonary Aspergillosis (Mycosis)
A1  - Fitzpatrick, Meghan E.
A1  - Prendergast, Niall T.
A1  - Rivera-Lebron, Belinda
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
Y1  - 2023
N1  - 
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Key  Clinical  Updates  in  Allergic  Bronchopulmonary  Aspergillosis  (Mycosis)For  patients  with  frequent  exacerbations,  the  use  of  biologic  agents,  such  as  anti-IgE  (omalizumab),  anti-IL-5  (mepolizumab,  benralizumab),  or  anti-IL4  receptor  (dupilumab),  has  been  shown  to  improve  outcomes.Koutsokera  A  et  al.  J  Cyst  Fibros.  [PMID:  31405730]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2023/12/02
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193145914
ER  -